Seroatlas · Human Serome Atlas

DNASE1L3

Deoxyribonuclease gamma

Also known as: DNAS1L3, DNSL3_HUMAN, LSD

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q13609
Gene
DNASE1L3
Ensembl
ENSG00000163687
Chromosome
3
Canonical length
305 aa
Protein class
Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins
Secretome location
Secreted to blood

OverviewNCBI Gene

This gene encodes a member of the deoxyribonuclease I family. The encoded protein hydrolyzes DNA, is not inhibited by actin, and mediates the breakdown of DNA during apoptosis. Mutations in this gene are a cause of systemic lupus erythematosus-16. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Feb 2012]

Canonical amino-acid sequenceUniProt

305 residues, UniProt reviewed canonical sequence.

>Q13609|DNASE1L3
     1  MSRELAPLLL LLLSIHSALA MRICSFNVRS FGESKQEDKN AMDVIVKVIK RCDIILVMEI
    61  KDSNNRICPI LMEKLNRNSR RGITYNYVIS SRLGRNTYKE QYAFLYKEKL VSVKRSYHYH
   121  DYQDGDADVF SREPFVVWFQ SPHTAVKDFV IIPLHTTPET SVKEIDELVE VYTDVKHRWK
   181  AENFIFMGDF NAGCSYVPKK AWKNIRLRTD PRFVWLIGDQ EDTTVKKSTN CAYDRIVLRG
   241  QEIVSSVVPK SNSVFDFQKA YKLTEEEALD VSDHFPVEFK LQSSRAFTNS KKSVTLRKKT
   301  KSKRS

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against DNASE1L3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Secreted
Secreted
Yes
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.26
Highest tissue expression
253 nTPM

Expression across tissuesHPA

Tissue

  • liver: 253 nTPM
  • spleen: 248 nTPM
  • tonsil: 51 nTPM
  • kidney: 45 nTPM
  • small intestine: 40 nTPM
  • adrenal gland: 40 nTPM

Single-cell type

  • pdcs: 307 nCPM
  • vascular endothelial cells: 135 nCPM
  • cdc: 130 nCPM
  • hepatic stellate cells: 116 nCPM
  • suprabasal keratinocytes: 114 nCPM
  • esophageal suprabasal cells: 98 nCPM

Immune cell

  • plasmacytoid DC: 426 nTPM
  • myeloid DC: 41 nTPM
  • naive B-cell: 21 nTPM
  • memory B-cell: 21 nTPM
  • total PBMC: 3.4 nTPM
  • neutrophil: 0.6 nTPM

Brain region

  • choroid plexus: 14 nTPM
  • cerebellum: 5.3 nTPM
  • white matter: 4.7 nTPM
  • pons: 4.2 nTPM
  • cerebral cortex: 4.1 nTPM
  • thalamus: 3.9 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about DNASE1L3.

Disease | AllUniProt

Conditions DNASE1L3 is implicated in, by any mechanism.

Disease | GeneticClinVar

16 pathogenic / likely-pathogenic of 292 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Disease | AutoantibodyPubMed

Conditions in which antibodies against DNASE1L3 are reported. Each links to that disease's full target list.

ReferencesPubMed · IEDB

Publications for DNASE1L3 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.

Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
1.12
gnomAD pLI
0
gnomAD missense Z
-0.03
DepMap mean gene effect
0.08
DepMap dependency class
none

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads DNASE1L3 as an antibody target. Whether an autoantibody or antibody against DNASE1L3 could matter depends on whether native DNASE1L3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

DNASE1L3 is annotated as secreted, so native DNASE1L3 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.

Annotation status

The present source text does not explicitly label DNASE1L3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/DNASE1L3. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...